
Inspire Medical Systems INSP
$ 56.45
-0.34%
Annual report 2025
added 02-13-2026
Country |
|
IPO year |
1998 |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
29.4 M |
Market Cap[1] |
$ 1.66 B |
EBITDA (LTM) |
$ 31.2 M |
P/E (LTM) |
60.26 |
P/S (LTM) |
1.97 |
EPS (LTM) |
0.94 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
$ 185.02 | -0.81 % | $ 13.9 B | Nasdaq Global Select Market,SPB | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Bruker Corporation
BRKR
|
$ 38.94 | -1.37 % | $ 5.8 K | Nasdaq Global Select Market,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 12.58 | -0.55 % | $ 1.7 B | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.61 | 3.18 % | $ 38 M | Nasdaq Capital Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.59 | 1.99 % | $ 134 M | Nasdaq Global Market | ||
|
Boston Scientific Corporation
BSX
|
$ 63.42 | -1.83 % | $ 93.9 B | NYSE,SPB | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
ClearPoint Neuro
CLPT
|
$ 10.5 | 0.38 % | $ 297 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Electromed
ELMD
|
$ 25.39 | -1.24 % | $ 215 M | NYSE American | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
LENSAR
LNSR
|
$ 5.8 | -7.2 % | $ 69.4 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 16.53 | -7.39 % | $ 388 M | Nasdaq Global Select Market,SPB | ||
|
Globus Medical
GMED
|
$ 92.76 | -1.87 % | $ 12.5 B | NYSE,SPB | ||
|
Helius Medical Technologies
HSDT
|
$ 2.06 | 6.19 % | $ 1.25 M | Nasdaq Capital Market | ||
|
Butterfly Network
BFLY
|
$ 5.29 | 8.74 % | $ 1.12 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Inogen
INGN
|
$ 6.59 | 6.29 % | $ 175 M | Nasdaq Global Select Market,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 1.04 | - | $ 17.6 M | Nasdaq Global Select Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Delcath Systems
DCTH
|
$ 10.83 | -1.46 % | $ 388 M | Nasdaq Capital Market | ||
|
CONMED Corporation
CNMD
|
$ 37.91 | -3.88 % | $ 1.18 B | NYSE,SPB | ||
|
LivaNova PLC
LIVN
|
$ 65.01 | -0.2 % | $ 3.55 B | Nasdaq Global Select Market | ||
|
Integer Holdings Corporation
ITGR
|
$ 88.37 | 0.49 % | $ 3.07 B | NYSE,SPB | ||
|
FONAR Corporation
FONR
|
$ 18.76 | -0.05 % | $ 123 M | Nasdaq Capital Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Edwards Lifesciences Corporation
EW
|
$ 79.05 | 1.09 % | $ 46.2 B | NYSE,SPB | ||
|
Sintx Technologies
SINT
|
$ 2.68 | -2.19 % | $ 7.43 M | Nasdaq Capital Market | ||
|
Penumbra
PEN
|
$ 331.47 | -0.29 % | $ 12.9 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.